Pearl mutants have a night-blind phenotype and abnormal optokinetic nystagmus. Preliminary results from another study 14 showed that the light responses of retinal ganglion cells of pearl mutant mice were affected by bathing the isolated retina with low (<1 riM) concentrations of either somatostatin-14 or -28, whereas the responses in wild-type retinas were affected only by somatostatin-28. In order to test the possibility that these physiological differences resulted from alterations in receptor affinity, we studied the binding of ~25I-[TyrH]-somatostatin-14 and 125I-[Leua,o-Trp22,Tyr25]-somatostatin-28 to frozen, unfixed sections of eyes of wild-type (C57BL/6J +/+) and congenic pearl mutant (C57BL/6J-pin pepm/pe pro) mice. As found previously for wild-type mice, specific binding occurred in 3 maxima in pearl mutants: a broad band extending from the retinal ganglion cell to the inner nuclear layer, a narrow and inconstant band over the outer plexiform layer, and a band over the pigment epithelium and choroid. We quantified the label over the inner plexiform layer and found evidence for a single saturable site in both genotypes. However, several results indicate that somatostatin-14 binds more avidly to pearl mutant retinas than to wild-type retinas. In saturation binding studies, K d for 12sI-[Tyrll]-somatostatin-14 was 600 pM in pearl mutants vs 1.5 nM in wild-type; whereas, for ~25I-[LeuS,o-TrpEE,Tyr25]-somatostatin-28, K o was nearly equal in the two genotypes (500 and 625 pM, respectively). Bma x was nearly equal for both ligands in both genotypes (63-69 fmol/mg protein). Somatostatin- (14) was also a more potent competitor in pearl mutant retinas (against 125I-[Tyrll]-somatostatin-14, K d was 250 pM for pearl mutants and 1.12 nM for wild-type; against 125I-[LeuS,o-TrpE2,TyrES]-somatostatin-28 these values were 640 pM and 3.77 nM, respectively). However, somatostatin-28 compared nearly equally in both genotypes (against 125I-[Tyrll]-somatostatin-14, K d was 510 pM for pearl mutants and 420 pM for wild-type; against 125I-[Leu8,D-Trp22,Tyr25]-somatostatin-28, K d was 1.28 and 1.20 nM, respectively). These results indicate that the greater affinity possessed by wild-type retinas for somatostatin-28 over somatostatin-14 is altered by the pearl mutation, elevating the affinity of the retina for somatostatin-14 is altered by the pearl mutation, elevating the affinity of the retina for somatostatin-14.
INTRODUCTION
A variety of visually defective mutants of the mouse that do not have retinal degeneration have been identified 1. One of these, the pearl mutant, results from a recessive mutation, and displays a night-blind phenotype when studied with recordings from the optic nerve fibers of anesthetized animals. Pearl mutants also show ultrastructural abnormalities of the basal membrane of the retinal pigment epithelium 16 and of the lamellae of the photoreceptor synapse 17. Recordings of the light responses of on-center retinal ganglion cells in the isolated, superfused retina 14 have shown that the application of low (<10 nM) concentrations of somatostatin-(28), but not somatostatin-14, increases the amplitude of the responses to a small, centered light stimulus. However, the responses of pearl mutant mice are increased by both molecular forms of somatostatin. We undertook the present studies to examine whether the electrophysiological differences between wild-type and pearl mutant may result from differences in the affinity of retinal receptors for the two molecular forms of somatostatin. Quantitative autoradiography has been employed to study the binding of somatostatin to the retinas of wild-type mice. Both saturation binding and binding competition studies have shown that the dissociation constant for the binding of somatostatin-28 to the wild-type retina is lower than the dissociation constant for the binding 7 of somatostatin-14. In the present study we examined the binding of both molecular forms of somatostatin to the retinas of pearl mutant mice, using simultaneously prepared specimens of both wild-type and pearl mutant genotypes. We found that, in contrast to the binding found in wild-type retinas, somatostatin-14 binds more avidly than somatostatin-28 to pearl mutant retinas.
MATERIALS AND METHODS

Quantitative autoradiography
Mice from the pearl mutant strain (C57BL/6J-pin pepin/pepin), 3 killed by cervical dislocation 3-4 h after light onset. The eyes were frozen (-140 °C) and mounted side-by-side in a cryostat chuck with eyes from wild-type mice of the congenic C57BL/6J strain. These eyes were sectioned together and mounted together on microscope slides. All further treatments were identical for the eye sections from both genotypes. After coding the slides, the sections were incubated with ~:5I-labeled somatostatin analogs according to the procedure of Maurer and Reubi n , rinsed and dried according to the procedure of Kossut et al. 7 and placed in X-ray cassettes with LKB ultrofilm. The ]~5I-[Leus,D-Trp22,Tyr25]-somatostatin-28 was produced using the chloramine-T method, as previously described ~2't8. The developed autoradiograms were superimposed upon the histological sections in order to identify the part of the autoradiogram that overlay the inner plexiform layer. The optical density of this part of the autoradiogram was measured with a microphotometer (60 pm aperture), and the distribution of density was measured with an Eikonix scanning microphotometer (7 pm pixel size). Calibration was accomplished using brain paste standards ~s. In a few cases we used emulsion autoradiography to confirm the localization of the label 7.
RESULTS
Anatomical localization of binding in the retina
The distribution of total binding in the eye of pearl mutant mice (Fig. 1A-C ) was similar to that of wild-type mice ( Fig. 1D-F) . With both 125I-[Tyrn]-somatostatin- (14) and t25I-[LeuS,D-Trp22,TyrZS]-somatostatin-28, the maxima of binding occurred in the retinal pigment epithelium-choroid complex (RPE-choroid complex), in a thin and inconstant band over the outer plexiform layer, and in a broad band over the inner plexiform layer and the inner margin of the inner nuclear layer (see Fig.  1A ,C). These maxima of total binding did not appear to have different intensities in the central and peripheral parts of the eye (Fig. 1A) . Non-specific binding (Fig. 1B) was higher in the RPE-choroid complex than in the retina, but in the retina the non-specific binding was lower and more uniform than total binding. By restricting our photometric measurements to the innermost 60 pm of the broad band of label in the retina 7 we quantified the binding in the inner plexiform layer.
Saturation binding studies
We measured the binding of 125I-[Tyrn]-somatostatin- (14) to the inner plexiform layer using concentrations from 30 pM to 5 nM. Non-specific binding was determined in the presence of 10 pM somatostatin-14, and accounted for 30-70% of the total binding. Specific binding was consistently greater in each of 7 paired experiments in pearl mutant retinas than in wild-type retinas for concentrations of 2 nM and less ( Fig. 2A) . Scatchard analysis of the averaged specific binding data ( Fig. 3A) was consistent with the presence of a single class of binding sites in pearl mutant retinas with a dissociation constant (Kd) of 600 pM. This dissociation constant is lower than that of wild-type retinas (1.48 nM, see ref. 7) . We noted that the Scatchard plots of the averaged binding data for pearl mutant retinas (Fig. 3A) , fell above the fitted line for a single site model for the 3 lowest values of bound ligand and below the fitted line for the next 3 higher values. We, therefore, compared the goodness-of-fit of a single site model with the goodnessof-fit of a two-site model, using the 'Ligand' program. For this comparison we used both the data from each of the 7 individual incubations and the averaged data from all incubations. The goodness-of-fit was only slightly Non-specific binding (B and E) was obtained in the presence of 10 /~M unlabeled somatostatin-14. The straight lines in the autoradiograms show the path along which optical transmission was measured. The layers of the retina that underlie the scan path were identified from the section and are indicated in the plots in C and F (RPE, retinal pigment epithelium and choroid; ROS, rod outer segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer and GC, ganglion cell layer). Note the high specific binding (hatched) in the inner plexiform layer. Scale bar, 60 pm.
better for the two-site model, and was, therefore, not considered further. The total number of binding sites (Bma~) in pearl mutant retinas (69 fmol/mg protein) was similar to that found in wild-type retinas (68 fmol/mg protein). We also measured the binding of 125I-[Leu8,D-Trp22, Tyr25]-somatostatin-28 using concentrations from 50 pM to 2.5 nM. Non-specific binding was determined in the presence of 10/aM somatostatin-28, and accounted for 20-50% of total binding. Specific binding (Fig. 2B ) was nearly equal in the two genotypes for each concentration of this ligand. Scatchard analysis (Fig. 3B) 
Binding competition studies
Somatostatin- (14) was a more potent competitor in pearl mutant retinas than in wild-type retinas against the binding of both 125I-[Tyr11]-somatostatin-14 ( Fig. 4A) IC5o in wild-type retinas were 2-3 fold higher, 640 pM and 3.77 nM, respectively 7.
Unlike somatostatin-14, somatostatin-28 was nearly equally potent in competing against both ligands (Fig.  5A,B) in pearl mutant and wild-type retinas. We found 
DISCUSSION
Pearl mutant mice have served as a useful model for studying congenital night blindness. Although we do not know the basis for this phenotype, we have observed previously that the mutants have a specific electrophysiologically observable abnormality 14. The light response of on-center retinal ganglion cells is increased in amplitude by somatostatin-28 and not by somatostatin-14 in wild-type animals. However, the responses of mutant animals are affected by both molecular forms. We reasoned that there are at least two explanations for these observations. One possibility is that the structure of somatostatin-14 in wild-type is different from that of the commercially available synthetic compound, based on the structure of somatostatin in other mammalian species. The corollary to this hypothesis is that the pearl mutants synthesize somatostatin-14 that is more similar to that found in the other mammalian species. We examined this possibility in previous studies and found that somatostatin of both wild-type and pearl mutant is identical to the commercially available somatostatin-14 (Aldrich et al., in preparation). An alternative explanation for our electrophysiological finding is that the pearl mutation results in an alteration of the affinity of retinal binding sites for somatostatin-14 and -28. Our current studies support this latter hypothesis.
Saturation binding and binding competition results, obtained with an experimental protocol that employed identically treated pairs of mutant and wild-type retinas, indicate that pearl mutant retinas bind somatostatin-14 more avidly than wild-type retinas. In saturation binding studies the amount of 125I-[Tyr11]-somatostatin-14 ligand bound with concentrations of ligand of 1250 pM and lower was greater in pearl mutant retinas. This increase was reflected in a lower dissociation constant for pearl mutant retinas (600 pM) than for wild-type retinas (1.48 nM). Binding competition results showed that the inhibitory binding constants (Ki) for somatostatin-14 were lower in pearl mutant retinas against both x25I-[Tyr11] -somatostatin-14 (240 pM) and 125I-[Leus,D-Trp22,TyrZS]-somatostatin-28 (430 pM) than in wild-type retinas (900 pM and 4.58 nM, respectively). However, no differences were found between mutant and wild-type retinas in saturation binding studies using 1asI-[Leu8,D-TrpZ2,TyrZS]-somatostatin-28 ligand or in the competition of somatostatin-28 against this ligand. We found that somatostatin-28 was slightly more effective in competing against 125I-[Tyrll]-somatostatin-14 in wild-type retinas than in pearl mutant retinas.
The present data do not permit us to say to what degree, if at all, the altered binding of somatostatin is responsible for the night-blind phenotype seen in pearl mutants. Perhaps recordings from retinal interneurons of the mouse that are post-synaptic to the somatostatincontaining amacrine cells will help clarify somatostatin's role in the appearance of the night-blind phenotype in pearl mutants.
The availability of a mutation with altered somatostatin binding may be useful for understanding the role and mechanism of action on this peptide in the retina. Immunohistochemical studies have found somatostatin in the processes of amacrine cells in the inner plexiform layer and in the processes of unidentified cells in the outer plexiform layer 6"13. The processes of these cells in the inner plexiform layer are presynaptic to amacrine, ganglion and bipolar cells 9'1°. Recently it has become possible to record membrane currents of solitary neurons of these cell types from mammalian retinas (ganglion cells, see ref. 8 ; bipolar cells, see ref. 5). It would not be surprising if various membrane currents of these cells were modified by somatostatin, as has been found in other neurons 2"4. The pearl mutation affects the somatostatin receptor molecule and therefore may be useful in studying the mechanism for somatostatin-induced modification of membrane currents.
